Skip to content
DataLookout
Menu

NCT06952816

Automated Oxygen Titration With the EMILY.AI Device in a Respiratory Intermediate Care Unit

StatusSuspended
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Study description shortened, about 61 words
  2. Stopped Recruitment suspended Sponsor's reason: Recruitment temporarily paused pending competent authority (AEMPS) approval of a protocol amendment. Recruitment will resume after approval. Not stopped for safety reasons. Show 9 more changesShow less
    • Primary and study completion dates pushed to Mar 30, 2027
    • Enrollment increased: 20 → 60 participants
    • Enrollment increased: 60 → 80 participants
    • Start date moved earlier from Jan 23, 2026 to Apr 15, 2025
    • Interventions modified
    • Trial arms changed: 3 → 4
    • Trial arms changed: 1 → 3
    • Study description expanded, about 51 words
    • Site details revised
  3. Notable Enrollment target: 20 to 60 Show 10 more changesShow less
    • Primary and study completion dates pushed to Mar 30, 2027
    • Start date: Apr 23, 2025 to Jan 23, 2026
    • Eligibility criteria expanded, about 123 words
    • Study sites: 2 to 1
    • Interventions: Emily.AI (Device) to Emily.AI (Device), Manual oxygen titration (Other)
    • Secondary endpoints: 5 to 9
    • Study description expanded, about 165 words
    • Collaborators: 2 to 1
    • Study title revised
    • Study arms: 1 to 3
  4. Minor Study description shortened, about 321 wordsv4
  5. Minor Study completion date: Jul 30, 2025 to Dec 30, 2026v3
  6. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    • Start date changed from estimate of Apr 21, 2025 to Apr 23, 2025
    v2
  7. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

EFFICACY - EVALUATION OF THE RATE THE DEVICE MAINTAINS BLOOD OXYGEN SATURATION LEVELS
Timeframe: During the monitoring session: approximately 5 hours of closed-loop titration followed by approximately 5 hours of manual titration on the same day (closed-loop period only in the initial phase).

Secondary (9)

ACCURACY - MEASUREMENT OF THE SYSTEM'S ACTION SPEED CORRECTING THE OXYGEN SATURATION LEVELS
ALERT SYSTEM - MEASUREMENT OF THE NUMBER OF SYSTEM ALERTS
ALERT SYSTEM - EVALUATION OF THE AUTHENTICITY OF THE SYSTEM ALERTS BY COMPARING THE OXYGEN SATURATION LEVELS WITH A CONVENTIONAL SYSTEM
EFFICIENCY - MEASUREMENT OF THE NUMBER OF TIMES THE MEDICAL AND NURSING TEAM MUST ADJUST THE OXYGENATION
VERSATILITY - COMPARISON OF BLOOD OXYGEN SATURATION LEVELS MAINTENANCE BETWEEN DIFFERENT PROFILES AND SITUATIONS
Show 4 moreShow less
SAFETY - TIME WITH OXYGEN SATURATION BELOW AND ABOVE THE TARGET RANGE
EFFICIENCY - OXYGEN FLOW DELIVERED
CLINICAL BENEFIT - DYSPNOEA, ACTIVITY TOLERANCE, COMFORT AND SATISFACTION
ADAPTABILITY - AGREEMENT BETWEEN PULSE OXIMETER MODELS

Arms and interventions

Paired phase: closed-loop then manual titrationExperimental

Participants enrolled January-April 2026 (CIP v4.0-v5.0). Same session: \~5 h closed-loop titration by EMILY.AI, then \~5 h manual titration by nursing staff with the device recording only.

Extension: adjusted control parameters (slow controller)Experimental

Participants enrolled June-July 2026 (CIP v6.0). Same paired session, with refined algorithm parameters.

Extension: adjusted minimum-flow parameterExperimental

Approximately 10 participants (CIP v8.0). Same paired session, with an adjusted parameter.

Initial phase: closed-loop onlyExperimental

Participants enrolled April-August 2025 and December 2025 (CIP v3.0-v5.0). EMILY.AI titrates oxygen in closed-loop mode under continuous physician supervision; no paired manual period.

Devices: Emily.AI

Other: Manual oxygen titration

Sites

1 site in 1 country

  • Hospital Universitario Fundación Jiménez DíazMadrid, Spain